Trial
NCT05037266
Cohort Assessing the Immunogenicity and the Safety of the COVID-19 Vaccine Janssen in Healthy Volunteers Based on 2 Age Groups: 65 Years or Older - 55 to 65 Years. Covicompare-Janssen
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Collaborators
—
Condition
Healthy Volunteers
Intervention
COVID-19 Vaccine Janssen (Ad26.COV2-S)
Why stopped
The study was stopped due to lack of inclusions
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-02-10